Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bunge Recasts Reporting Segments After Viterra Merger; Sets FY25 Adjusted EPS Outlook At $7.30–$7.60 vs $7.42 Est (Prior View: $7.75)

Author: Benzinga Newsdesk | October 15, 2025 05:05am

Posted In: BG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist